This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Atopic Dermatitis
and you are
between 2 and 6
years old
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this study is to assess the clinical effectiveness of Montelukast in children (2~6 years old) with atopic dermatitis and identify the pathophysiologic background of Montelukast on the role of modulating the atopic dermatitis measured by urinary Leukotriene 4 (LTE4) and Eosinophil protein X(EDN).

Provided treatments

  • Drug: Montelukast first, then placebo
  • Drug: Placebo first, then Montelukast
Tris trial is registered with FDA with number: NCT00903357. The sponsor of the trial is Pyun BokYang and it is looking for 54 volunteers for the current phase.
Official trial title:
A Double Blind, Randomized, Crossover Study to Compare the Effectiveness of Montelukast on Atopic Dermatitis in Koreans